Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Allopurinol and Placebo in Gout (APEX)
NCT00174915Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2003
- Primary completion
- Apr 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of febuxostat in gout (5 arms), sponsored by Takeda. Primary endpoint: Percentage of Subjects Whose Last Three Serum Urate Levels Are <6.0 mg/dL. Started Feb 2003; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT00174915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174915.